跳至主要内容
临床试验/NL-OMON49161
NL-OMON49161已完成不适用

Feasibility of Splenic Nerve Stimulation During Esophagectomy - Splenic Nerve Stimulation During Esophagectomy

Galvani Bioelectronics0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Female of non-reproductive potential or male
  • * Undergoing minimally invasive esophagectomy
  • * Confirmed presence of splenic NVB loop via imaging prior to surgery
  • * Age equal or above 21 years at the screening visit
  • * Capable of giving signed informed consent (IC)
  • * Normal blood pressure, or hypertensive managed with medication such that they
  • are deemed fit for surgery

排除标准

  • * Previous splenectomy
  • * Existing implantable device
  • * Active pancreatitis or history of severe pancreatitis with complications,
  • hepatic or splenic disease
  • * Use of oral steroids 4 weeks prior to inclusion
  • * Current use immunosuppressive agents or biologicals. Previous use of
  • biologicals is allowed, if a washout period of 2 months is applied
  • * Use of anticoagulants within 1 week of surgery

研究者

相似试验